Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Hartmann

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Journal of Enzyme Inhibition|January 1, 1995
Evaluation of 6,7-aziridinyl steroids and related compounds as inhibitors of aromatase (P-450arom)V C Njar, G Grün, R W Hartmann
The Journal of Steroid Biochemistry and Molecular Biology|February 17, 2001
Development of a simple and rapid assay for the evaluation of inhibitors of human 17alpha-hydroxylase-C(17,20)-lyase (P450cl7) by coexpression of P450cl7 with NADPH-cytochrome-P450-reductase in Escherichia coliP B Ehmer, J Jose, R W Hartmann
Journal of Cancer Research and Clinical Oncology|January 1, 1982
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the ratR W Hartmann, H Schönenberger, K H Wrobel
Archiv Der Pharmazie|February 1, 1990
[Antiestrogenic N-(4-hydroxyphenyl)-n-(1,1,1,-trifluoro-2-propyl)-4- hydroxybenzamides: influence of hydrophobic groups substituted in the ortho-position of the benzamide-fragment on activity]R W Hartmann, H D vom Orde, H Schönenberger
Journal of Medicinal Chemistry|September 1, 1985
Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanesR W Hartmann, W Schwarz, A Heindl, et al.
Journal of Medicinal Chemistry|May 5, 2000
1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromataseC Jacobs, M Frotscher, G Dannhardt, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 12, 2001
Stable expression of human 5alpha-reductase type II in COS1 cells due to chromosomal gene integration: a novel tool for inhibitor identificationW Reichert, A Michel, R W Hartmann, et al.
Clinical Pediatrics|October 1, 1990
Poland's syndromeM J Lord, K R Laurenzano, R W Hartmann
The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1992
Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide typeR W Hartmann, G Grün, U Bartz, et al.
Journal of Medicinal Chemistry|July 1, 1984
Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrolsR W Hartmann, A Heindl, W Schwarz, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Journal of Enzyme Inhibition|January 1, 1995
Evaluation of 6,7-aziridinyl steroids and related compounds as inhibitors of aromatase (P-450arom)V C Njar, G Grün, R W Hartmann
The Journal of Steroid Biochemistry and Molecular Biology|February 17, 2001
Development of a simple and rapid assay for the evaluation of inhibitors of human 17alpha-hydroxylase-C(17,20)-lyase (P450cl7) by coexpression of P450cl7 with NADPH-cytochrome-P450-reductase in Escherichia coliP B Ehmer, J Jose, R W Hartmann
Journal of Cancer Research and Clinical Oncology|January 1, 1982
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the ratR W Hartmann, H Schönenberger, K H Wrobel
Archiv Der Pharmazie|February 1, 1990
[Antiestrogenic N-(4-hydroxyphenyl)-n-(1,1,1,-trifluoro-2-propyl)-4- hydroxybenzamides: influence of hydrophobic groups substituted in the ortho-position of the benzamide-fragment on activity]R W Hartmann, H D vom Orde, H Schönenberger
Journal of Medicinal Chemistry|September 1, 1985
Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanesR W Hartmann, W Schwarz, A Heindl, et al.
Journal of Medicinal Chemistry|May 5, 2000
1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromataseC Jacobs, M Frotscher, G Dannhardt, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 12, 2001
Stable expression of human 5alpha-reductase type II in COS1 cells due to chromosomal gene integration: a novel tool for inhibitor identificationW Reichert, A Michel, R W Hartmann, et al.
Clinical Pediatrics|October 1, 1990
Poland's syndromeM J Lord, K R Laurenzano, R W Hartmann
The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1992
Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide typeR W Hartmann, G Grün, U Bartz, et al.
Journal of Medicinal Chemistry|July 1, 1984
Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrolsR W Hartmann, A Heindl, W Schwarz, et al.
Pageof 9